| Description | 1
Day Price Change % | Market Cap | P/E  | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | 0.06 | 2198.5B | 17.64 | 14.66 | 2.14 | 0.78 | 9.94 | 11.98 | 74.53 |
| Industry: Drug Manufacturers - Major (More Info) | -0.13 | 1018.6B | 14.40 | 21.50 | 3.69 | 0.54 | 9.30 | 18.30 | 84.10 |
| Companies | |||||||||
| APP Pharmaceuticals, Inc. (APPX) | 0.47 | 3.8B | 115.05 | 14.99 | NA | NA | NA | 12.07 | 330.89 |
| Chem Rx Corporation (CHRX.OB) | 0.00 | 55.2M | 62.50 | 1.79 | NA | 2.02 | 0.83 | -0.30 | 8.14 |
| WuXi PharmaTech (Cayman) Inc. (WX) | -1.40 | 1.1B | 32.02 | 22.82 | NA | 0.17 | 3.57 | 12.03 | NA |
| Abbott Laboratories (ABT) | -0.33 | 88.7B | 21.46 | 24.38 | 2.50 | 0.73 | 4.68 | 18.07 | 140.42 |
| Aceto Corp. (ACET) | 1.82 | 191.6M | 20.05 | 7.58 | 2.60 | 0.00 | 1.43 | 3.35 | -17.74 |
| Bristol-Myers Squibb Co. (BMY) | 0.00 | 43.4B | 19.91 | 20.03 | 5.60 | 0.73 | 4.03 | 14.68 | NA |
| Johnson & Johnson (JNJ) | -0.13 | 197.6B | 17.16 | 26.46 | 2.60 | 0.30 | 4.26 | 20.23 | 150.91 |
| Merck & Co. Inc. (MRK) | 1.20 | 75.9B | 15.58 | 25.00 | 4.30 | 0.25 | 3.75 | 29.22 | 160.03 |
| Pfizer Inc. (PFE) | -1.18 | 130.0B | 14.50 | 13.45 | 6.60 | 0.25 | 1.96 | 22.89 | 31.92 |
| Glaxosmithkline plc (GSK) | 1.35 | 119.9B | 13.67 | 54.40 | 4.50 | 1.84 | 8.71 | 21.89 | 127.13 |
| Eli Lilly & Co. (LLY) | -1.05 | 53.5B | 13.51 | 28.93 | 4.00 | 0.31 | 3.63 | 18.62 | 35.94 |
| Wyeth (WYE) | 0.43 | 56.6B | 12.83 | 24.92 | 2.70 | 0.58 | 2.86 | 18.87 | 48.81 |
| Sanofi-Aventis (SNY) | -0.89 | 90.3B | 12.68 | 11.29 | 3.20 | 0.16 | 1.48 | 6.77 | NA |
| Novartis AG (NVS) | -0.62 | 123.8B | 10.17 | 14.80 | 2.70 | 0.21 | 2.40 | 20.46 | 134.28 |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 19.9M | NA | NA | NA | NA | 9.89 | NA | -53.08 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.2M | NA | NA | NA | NA | NA | NA | NA |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Spectrum Pharmaceuticals, Inc. (SPPI) | 0.56 | 56.7M | NA | -29.99 | NA | NA | 1.06 | 51.64 | 10.41 |
| Schering-Plough Corp. (SGP) | 0.52 | 31.7B | NA | -18.30 | 1.30 | 0.83 | 3.58 | 8.86 | 50.28 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 0.54 | 813.2M | NA | -72.84 | NA | 0.01 | 5.01 | NA | -43.05 |
| Quick-Med Technologies Inc. (QMDT.OB) | -14.29 | 9.2M | NA | NA | NA | NA | NA | -146.70 | -33.99 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 0.00 | 69.8M | NA | -75.18 | NA | NA | 5.57 | NA | -20.04 |
| Oscient Pharmaceuticals Corp. (OSCI) | 0.88 | 16.4M | NA | NA | NA | NA | NA | -82.75 | -2.24 |
| Novogen Limited (NVGN) | 2.01 | 137.7M | NA | -41.62 | NA | NA | 3.79 | -140.78 | -39.15 |
| Neurologix Inc. (NRGX.OB) | 0.00 | 22.2M | NA | -44.27 | NA | NA | 1.00 | NA | -19.76 |
| Minrad International Inc. (BUF) | 0.00 | 91.2M | NA | -144.98 | NA | 4.72 | 10.22 | -281.41 | -6.64 |
| Keryx Biopharmaceuticals Inc. (KERX) | 7.69 | 18.9M | NA | -195.25 | NA | NA | 3.65 | NA | -5.31 |
| Javelin Pharmaceuticals, Inc. (JAV) | -0.73 | 165.5M | NA | -78.54 | NA | NA | 3.79 | NA | -26.23 |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| HST Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| GeoPharma Inc. (GORX) | -6.88 | 33.1M | NA | -29.09 | NA | 0.83 | 1.03 | -13.06 | 10.62 |
| Evotec AG (EVTC) | -3.16 | 400.5M | NA | -30.30 | NA | 0.06 | 1.41 | -166.79 | -80.48 |
| CPEX Pharmaceuticals, Inc. (CPEX) | 0.00 | 41.2M | NA | NA | NA | NA | 1.92 | -42.73 | -31.80 |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | 6.25 | 8.0M | NA | NA | NA | NA | NA | NA | -5.16 |
| Avigen Inc. (AVGN) | 0.86 | 104.2M | NA | -40.98 | NA | 0.12 | 1.84 | NA | -22.62 |
| AstraZeneca plc (AZN) | NA | NA | NA | 37.20 | 2.30 | 0.93 | NA | 20.36 | NA |
| AP Pharma Inc. (APPA) | -1.34 | 45.4M | NA | -84.01 | NA | NA | 2.64 | NA | -10.47 |